mRNA
-
healthModerna CEO Warns Europe Is Vulnerable Without mRNA Manufacturing Capacity
Stéphane Bancel cautions that continental Europe lacks industrial mRNA infrastructure, leaving it exposed to future pandemics or bioterrorism, as Moderna shifts strategy toward cancer vaccines.
-
healthModerna Receives $50 Million to Develop mRNA Ebola Vaccine
CEPI funds Moderna, IAVI, and Oxford to develop vaccines against the deadly Bundibugyo Ebola strain currently raging in the DRC.
-
healthEurope Approves Moderna's First mRNA Flu-COVID Vaccine, mCOMBRIAX
Moderna's mCOMBRIAX, the world's first mRNA combo vaccine for flu and COVID-19, receives European authorization, offering a simplified immunization option.
-
techEurope's Health Revolution: Women Driving Medical Breakthroughs
Discover the groundbreaking contributions of women in European biotech and medicine, from cancer tests to vaccines, and the ongoing fight for recognition.
-
healthSingle Vaccine Targets Flu and COVID-19, Shows Promising Results
New multicomponent mRNA vaccine demonstrates safety and robust immune response against influenza and COVID-19 in early trials.